Breaking News: New Dexcom CGM 7 60% Smaller Than The G7
SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA
Read MoreSAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA
Read MoreNadia Al-Samarrie I recently interviewed Dan Pollom, senior medical advisor at Lilly, about Lyumjev – a fast-acting insulin approved in
Read MoreDexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) systems for people with diabetes, announced today a new patient
Read MoreDear Nadia: I have had type-2 diabetes for more than ten years. I was first enthusiastic about lancing to see
Read MoreDexcom- a company that has become synonymous with continuous glucose monitor systems for many diabetics, presented proof at the American
Read MoreClick here to listen to the audio recording of Diabetes Health in The News. The U.S. Food and Drug Administration
Read MoreVice President of Global Access at Dexcom, Claudia Graham not only has type 1 diabetes, but she is someone who
Read MoreCrossword Puzzle Posted on Previous Day
Read MoreI remember first seeing Kris Freeman when he was 21 at a diabetes conference. Two years after he was diagnosed
Read MoreTandem Diabetes Care, Inc. has teamed with Dexcom to expand an existing partnership to include development of Dexcom’s latest continuous
Read MoreThe FDA has approved U.S. sales of Dexcom’s G4TM PLATINUM continuous glucose monitor. The San Diego-based manufacturer said it is
Read More